Regulatory Requirements for Early Phase Drug Product Development
June 17, 2019 / ALLISON IRRERA
Supporting a compound from discovery to clinical phases and potentially commercial phases requires an immense amount of time, energy, and money. Regulatory management is paramount during the drug development pipeline funnel, and recognizing Current Good Manufacturing Practices (cGMPs) is the foundation of drug safety and efficacy.